Profil
Arvid Carlsson, M.D., Ph.D., has been a consultant to the Company since April 2002.
A co-recipient of the 2000 Nobel Prize for Medicine, Dr. Carlsson is currently Chief Executive Officer of Carlsson Research, a development stage neuroscience company that grew out of his research in the Department of Pharmacology at the University of Goteborg, Sweden.
Dr. Carlsson is Professor Emeritus at the University of Goteborg, and is a member of the Swedish Academy of Sciences and a foreign affiliate of the U.S.
National Academy of Sciences.
Dr. Carlsson has authored several hundred articles, which have helped to form the basis of modern neuropsychopharmacology.
In 1975, he was elected as a Foreign Corresponding Fellow of The American College of Neuropsychopharmacology.
In addition to the Nobel Prize, he has been the recipient of The Japan Prize in Psychology and Psychiatry, The Research Prize of the Lundbeck Foundation (Denmark) and the Lieber Prize (USA) for research in schizophrenia.
Dr. Carlsson's memberships include Member of the Academia Europaea, Member of the Royal Swedish Academy of Sciences, Honorary Fellow of the World Federation of Societies of Biological Psychiatry, Honorary Foreign Associate of the Institute of Medicine, National Academy of Sciences, U.S.A. and Honorary Member of the German Society of Biological Psychiatry.
Dr. Carlsson received his M.D.
and Ph.D.
in Pharmacology from the University of Lund, Sweden.
Postes actifs de Arvid M. Carlsson
| Sociétés | Poste | Début |
|---|---|---|
Royal Swedish Academy of Sciences
Royal Swedish Academy of Sciences Miscellaneous Commercial ServicesCommercial Services Provides research and development services on sciences | Corporate Officer/Principal | - |
University of Gothenburg
University of Gothenburg Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 24/01/2011 |
Anciens postes connus de Arvid M. Carlsson
| Sociétés | Poste | Fin |
|---|---|---|
A. Carlsson Research AB
A. Carlsson Research AB Pharmaceuticals: MajorHealth Technology Develops and discovery and clinical development of new pharmacological treatment principles for psychiatric and neurological disorders | Directeur Général | 31/12/2021 |
| RESPIRERX PHARMACEUTICALS INC. | Directeur/Membre du Conseil | - |
Formation de Arvid M. Carlsson
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
RespireRx Pharmaceuticals, Inc.
RespireRx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates biopharmaceutical company that discovers and develops drug therapies for the treatment of sleep apnea, respiratory depression & other brain-mediated breathing disorders | Health Technology |
Royal Swedish Academy of Sciences
Royal Swedish Academy of Sciences Miscellaneous Commercial ServicesCommercial Services Provides research and development services on sciences | Commercial Services |
University of Lund
University of Lund Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
A. Carlsson Research AB
A. Carlsson Research AB Pharmaceuticals: MajorHealth Technology Develops and discovery and clinical development of new pharmacological treatment principles for psychiatric and neurological disorders | Health Technology |
University of Gothenburg
University of Gothenburg Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
















